US Stock MarketDetailed Quotes

Lifecore Biomedical (LFCR)

Watchlist
  • 4.500
  • -0.060-1.32%
Close May 13 16:00 ET
  • 4.500
  • 0.0000.00%
Post 16:00 ET
168.79MMarket Cap-5.92P/E (TTM)

Lifecore Biomedical (LFCR) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(Q3)Sep 30, 2025
(FY)May 25, 2025
(Q4)May 25, 2025
(Q2)Nov 24, 2024
(Q1)Aug 25, 2024
(FY)May 26, 2024
(Q4)May 26, 2024
(Q3)Feb 25, 2024
(Q2)Nov 26, 2023
Total revenue
23.19M
-12.87%31.11M
0.47%128.87M
-3.81%36.44M
8.01%32.56M
0.75%24.71M
24.20%128.26M
21.64%37.89M
34.55%35.7M
37.90%30.15M
Operating revenue
--23.19M
-12.87%31.11M
0.47%128.87M
-3.81%36.44M
8.01%32.56M
0.75%24.71M
24.20%128.26M
21.64%37.89M
34.55%35.7M
37.90%30.15M
Cost of revenue
18.73M
-2.07%23.32M
2.50%88.57M
8.96%22.46M
6.37%21.48M
-11.36%19.32M
14.78%86.41M
-11.78%20.61M
32.37%23.81M
24.76%20.19M
Gross profit
4.46M
-34.50%7.79M
-3.71%40.3M
-19.05%13.98M
11.32%11.08M
97.47%5.39M
49.54%41.85M
122.03%17.27M
39.14%11.89M
75.33%9.96M
Operating expense
9.13M
-9.65%10.86M
6.66%52.3M
-22.97%11.08M
14.01%13.04M
49.50%16.97M
2.79%49.04M
-0.15%14.39M
-3.96%12.02M
9.29%11.44M
Selling and administrative expenses
--7.92M
-9.68%8.9M
8.86%44.05M
-26.55%8.98M
19.02%11.12M
60.60%14.79M
3.83%40.46M
-0.55%12.23M
-4.19%9.85M
12.68%9.34M
Research and development costs
--1.22M
-9.54%1.96M
-3.70%8.26M
-2.68%2.1M
-8.29%1.92M
1.86%2.19M
-1.84%8.58M
2.17%2.16M
-2.86%2.17M
-3.63%2.1M
Operating profit
-4.67M
-2,373.39%-3.07M
-67.03%-12.01M
0.49%2.9M
-32.10%-1.96M
-34.32%-11.58M
63.55%-7.19M
143.51%2.89M
96.87%-124K
69.03%-1.48M
Net non-operating interest income expense
-7.22M
-47.49%-6.33M
-20.70%-21.84M
4.65%-5.52M
-34.18%-5.47M
-36.31%-5.37M
-2.90%-18.09M
2.01%-5.79M
11.26%-4.29M
-12.89%-4.07M
Non-operating interest income
--128K
--58K
474.14%333K
----
----
--15K
--58K
----
----
----
Non-operating interest expense
--7.35M
48.85%6.38M
22.15%22.17M
0.10%5.85M
34.18%5.47M
36.69%5.38M
3.23%18.15M
-1.03%5.85M
-11.26%4.29M
12.89%4.07M
Other net income (expense)
-3.05M
-101.36%-265K
-113.89%-4.83M
135.58%1.51M
-95.46%896K
1,642.50%697K
230.66%34.79M
82.51%-4.24M
888.59%19.42M
2,566.63%19.73M
Gain on sale of security
---3.16M
-101.79%-375K
-98.96%409K
54.54%-1.09M
-94.20%1.2M
350.00%900K
--39.5M
---2.4M
--21M
--20.7M
Special income (charges)
--0
----
-216.36%-5.24M
429.89%2.43M
----
-4,930.00%-483K
93.59%-1.66M
96.90%-736K
69.95%-771K
----
-Less:Restructuring and merger&acquisition
----
----
-205.50%-1.75M
-441.33%-2.52M
----
4,930.00%483K
-60.42%1.66M
9,125.00%738K
-69.95%771K
----
-Gain on sale of business
----
----
----
----
----
----
--0
----
----
----
-Gain on sale of property,plant,equipment
--0
----
---6.99M
-4,650.00%-91K
----
----
--0
--2K
--0
----
Other non- operating income (expenses)
--110K
113.51%110K
99.90%-3K
115.52%171K
68.56%-304K
-19.41%-203K
-276.79%-3.05M
-129.58%-1.1M
-882.69%-814K
-308.02%-967K
Income before tax
-14.94M
-164.38%-9.66M
-506.50%-38.67M
84.40%-1.11M
-146.05%-6.53M
-29.81%-16.26M
114.88%9.51M
80.57%-7.14M
233.23%15M
254.15%14.18M
Income tax
43K
53.46%333K
-76.50%43K
157.89%33K
166.15%43K
-128.41%-25K
-40.58%183K
-124.78%-57K
210.00%217K
-1,725.00%-65K
Net income
-14.98M
-163.91%-9.99M
-422.29%-38.72M
83.81%-1.15M
-146.22%-6.57M
-50.92%-16.23M
112.07%12.01M
81.97%-7.08M
142.82%15.63M
211.03%14.22M
Net income continuous Operations
---14.98M
-167.58%-9.99M
-514.93%-38.72M
83.81%-1.15M
-146.14%-6.57M
-28.71%-16.23M
114.53%9.33M
80.85%-7.09M
230.49%14.79M
254.79%14.24M
Net income discontinuous operations
----
----
--0
--0
--0
--0
107.59%2.68M
100.13%3K
103.36%847K
99.33%-24K
Minority interest income
Net income attributable to the parent company
-14.98M
-163.91%-9.99M
-422.29%-38.72M
83.81%-1.15M
-146.22%-6.57M
-50.92%-16.23M
112.07%12.01M
81.97%-7.08M
142.82%15.63M
211.03%14.22M
Preferred stock dividends
907K
874K
3.32M
852K
Other preferred stock dividends
47K
48K
2.32M
48K
2.13M
0
0
0
0
0
Net income attributable to common stockholders
-15.93M
-169.81%-10.91M
-469.26%-44.36M
71.10%-2.05M
-161.21%-8.7M
-50.92%-16.23M
112.07%12.01M
81.97%-7.08M
142.82%15.63M
211.03%14.22M
Basic earnings per share
-0.43
-156.86%-0.29
-425.64%-1.27
75.00%-0.06
-153.19%-0.25
-51.43%-0.53
111.75%0.39
79.83%-0.24
142.50%0.51
209.30%0.47
Diluted earnings per share
-0.43
-169.05%-0.29
-484.85%-1.27
75.00%-0.06
-164.10%-0.25
-51.43%-0.53
109.94%0.33
79.83%-0.24
135.00%0.42
190.70%0.39
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q1)Mar 31, 2026(Q3)Sep 30, 2025(FY)May 25, 2025(Q4)May 25, 2025(Q2)Nov 24, 2024(Q1)Aug 25, 2024(FY)May 26, 2024(Q4)May 26, 2024(Q3)Feb 25, 2024(Q2)Nov 26, 2023
Total revenue 23.19M-12.87%31.11M0.47%128.87M-3.81%36.44M8.01%32.56M0.75%24.71M24.20%128.26M21.64%37.89M34.55%35.7M37.90%30.15M
Operating revenue --23.19M-12.87%31.11M0.47%128.87M-3.81%36.44M8.01%32.56M0.75%24.71M24.20%128.26M21.64%37.89M34.55%35.7M37.90%30.15M
Cost of revenue 18.73M-2.07%23.32M2.50%88.57M8.96%22.46M6.37%21.48M-11.36%19.32M14.78%86.41M-11.78%20.61M32.37%23.81M24.76%20.19M
Gross profit 4.46M-34.50%7.79M-3.71%40.3M-19.05%13.98M11.32%11.08M97.47%5.39M49.54%41.85M122.03%17.27M39.14%11.89M75.33%9.96M
Operating expense 9.13M-9.65%10.86M6.66%52.3M-22.97%11.08M14.01%13.04M49.50%16.97M2.79%49.04M-0.15%14.39M-3.96%12.02M9.29%11.44M
Selling and administrative expenses --7.92M-9.68%8.9M8.86%44.05M-26.55%8.98M19.02%11.12M60.60%14.79M3.83%40.46M-0.55%12.23M-4.19%9.85M12.68%9.34M
Research and development costs --1.22M-9.54%1.96M-3.70%8.26M-2.68%2.1M-8.29%1.92M1.86%2.19M-1.84%8.58M2.17%2.16M-2.86%2.17M-3.63%2.1M
Operating profit -4.67M-2,373.39%-3.07M-67.03%-12.01M0.49%2.9M-32.10%-1.96M-34.32%-11.58M63.55%-7.19M143.51%2.89M96.87%-124K69.03%-1.48M
Net non-operating interest income expense -7.22M-47.49%-6.33M-20.70%-21.84M4.65%-5.52M-34.18%-5.47M-36.31%-5.37M-2.90%-18.09M2.01%-5.79M11.26%-4.29M-12.89%-4.07M
Non-operating interest income --128K--58K474.14%333K----------15K--58K------------
Non-operating interest expense --7.35M48.85%6.38M22.15%22.17M0.10%5.85M34.18%5.47M36.69%5.38M3.23%18.15M-1.03%5.85M-11.26%4.29M12.89%4.07M
Other net income (expense) -3.05M-101.36%-265K-113.89%-4.83M135.58%1.51M-95.46%896K1,642.50%697K230.66%34.79M82.51%-4.24M888.59%19.42M2,566.63%19.73M
Gain on sale of security ---3.16M-101.79%-375K-98.96%409K54.54%-1.09M-94.20%1.2M350.00%900K--39.5M---2.4M--21M--20.7M
Special income (charges) --0-----216.36%-5.24M429.89%2.43M-----4,930.00%-483K93.59%-1.66M96.90%-736K69.95%-771K----
-Less:Restructuring and merger&acquisition ---------205.50%-1.75M-441.33%-2.52M----4,930.00%483K-60.42%1.66M9,125.00%738K-69.95%771K----
-Gain on sale of business --------------------------0------------
-Gain on sale of property,plant,equipment --0-------6.99M-4,650.00%-91K----------0--2K--0----
Other non- operating income (expenses) --110K113.51%110K99.90%-3K115.52%171K68.56%-304K-19.41%-203K-276.79%-3.05M-129.58%-1.1M-882.69%-814K-308.02%-967K
Income before tax -14.94M-164.38%-9.66M-506.50%-38.67M84.40%-1.11M-146.05%-6.53M-29.81%-16.26M114.88%9.51M80.57%-7.14M233.23%15M254.15%14.18M
Income tax 43K53.46%333K-76.50%43K157.89%33K166.15%43K-128.41%-25K-40.58%183K-124.78%-57K210.00%217K-1,725.00%-65K
Net income -14.98M-163.91%-9.99M-422.29%-38.72M83.81%-1.15M-146.22%-6.57M-50.92%-16.23M112.07%12.01M81.97%-7.08M142.82%15.63M211.03%14.22M
Net income continuous Operations ---14.98M-167.58%-9.99M-514.93%-38.72M83.81%-1.15M-146.14%-6.57M-28.71%-16.23M114.53%9.33M80.85%-7.09M230.49%14.79M254.79%14.24M
Net income discontinuous operations ----------0--0--0--0107.59%2.68M100.13%3K103.36%847K99.33%-24K
Minority interest income
Net income attributable to the parent company -14.98M-163.91%-9.99M-422.29%-38.72M83.81%-1.15M-146.22%-6.57M-50.92%-16.23M112.07%12.01M81.97%-7.08M142.82%15.63M211.03%14.22M
Preferred stock dividends 907K874K3.32M852K
Other preferred stock dividends 47K48K2.32M48K2.13M00000
Net income attributable to common stockholders -15.93M-169.81%-10.91M-469.26%-44.36M71.10%-2.05M-161.21%-8.7M-50.92%-16.23M112.07%12.01M81.97%-7.08M142.82%15.63M211.03%14.22M
Basic earnings per share -0.43-156.86%-0.29-425.64%-1.2775.00%-0.06-153.19%-0.25-51.43%-0.53111.75%0.3979.83%-0.24142.50%0.51209.30%0.47
Diluted earnings per share -0.43-169.05%-0.29-484.85%-1.2775.00%-0.06-164.10%-0.25-51.43%-0.53109.94%0.3379.83%-0.24135.00%0.42190.70%0.39
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More